Skip to main content
OpenTrials

Clinical trial condition

Lymphangiomyoma

Explore clinical trials studying Lymphangiomyoma. Study availability and eligibility vary by location and protocol.

39 public trials 10 recruiting studies
Refine in advanced search Browse all conditions

Lymphangiomyoma trial results

Completed

Letrozole for Lymphangioleiomyomatosis

NCT01353209

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • Stanford University Medical Center Stanford, California, United States
  • Mayo Clinic Jacksonville, Florida, United States
  • University of Miami Miami, Florida, United States
  • Emory University School of Medicine Atlanta, Georgia, United States
View Trial Details
Completed

Efficacy and Safety of Sirolimus in LAM

NCT00414648

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • National Jewish Medical and Research Center Denver, Colorado, United States
  • University of Florida, Gainesville Gainesville, Florida, United States
  • National Heart, Lung, and Blood Institute Bethesda, Maryland, United States
View all 13 locations
View Trial Details
Completed

Safety and Efficacy of Everolimus (Afinitor®) in Chinese Adult Patients With Angiomyolipoma Associated With Tuberous Sclerosis Complex.

NCT03525834

Conditions
Angiomyolipoma, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +26 more
Locations
  • Novartis Investigative Site Wuhan, Hubei, China
  • Novartis Investigative Site Shanghai, Shanghai Municipality, China
  • Novartis Investigative Site Chengdu, Sichuan, China
  • Novartis Investigative Site Beijing, China
View Trial Details

Related conditions